Thyroid dysfunction following pregnancy and implications for breastfeeding

被引:15
|
作者
Amino, Nobuyuki [1 ]
Arata, Naoko [2 ]
机构
[1] Amino Thyroid Res Lab, 5-60-38 Nanpeidai, Takatsuki, Osaka 5691042, Japan
[2] Natl Ctr Child Hlth & Dev, Ctr Maternal Fetal Neonatal & Reprod Med, Div Maternal Med, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan
关键词
postpartum thyroiditis; Graves' disease; postpartum thyroid dysfunction; breastfeeding; hypothyroidism; thyrotoxicosis; POSTPARTUM GRAVES THYROTOXICOSIS; PEROXIDASE ANTIBODIES; INTELLECTUAL-DEVELOPMENT; RECEPTOR ANTIBODIES; ANTITHYROID DRUGS; HUMAN-MILK; DISEASE; DIFFERENTIATION; MOTHERS; HYPOTHYROIDISM;
D O I
10.1016/j.beem.2020.101438
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Subclinical autoimmune thyroiditis exacerbates after delivery through immune rebound mechanisms and results in 5 types of thyroid dysfunction. The prevalence of postpartum thyroid dysfunction is around 5% in mothers in the general population. Typically, an exacerbation induces destructive thyrotoxicosis followed by transient hypothyroidism, known as postpartum thyroiditis. Late development of permanent hypothyroidism is found frequently and patients should be followed up once every one to two years. Destructive thyrotoxicosis in postpartum thyroiditis should carefully be differentiated from post-partum Graves' disease. Postpartum thyroiditis typically occurs 1-4 months after parturition whereas Graves' disease develops at 4-12 months postpartum. Anti-TSH receptor antibodies (TRAb) are typically positive and thyroid blood flow is high in Graves' disease, whereas these features are absent in postpartum thyroiditis. Postpartum Graves' disease should be treated with antithyroid drugs. (C) 2020 Published by Elsevier Ltd.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Marijuana Use During Pregnancy and Breastfeeding: Implications for Neonatal and Childhood Outcomes
    Ryan, Sheryl A.
    Ammerman, Seth D.
    O'Connor, Mary E.
    PEDIATRICS, 2018, 142 (03)
  • [42] Pregnancy, Fetal, and Infant Outcomes Following Maternal Exposure to Glatiramer Acetate During Pregnancy and Breastfeeding
    Kaplan, Sigal
    Zeygarnik, Mikhail
    Stern, Tal
    DRUG SAFETY, 2022, 45 (04) : 345 - 357
  • [43] Postpartum Breastfeeding and Cardiovascular Risk Assessment in Women Following Pregnancy Complications
    Yu, Julie
    Pudwell, Jessica
    Dayan, Natalie
    Smith, Graeme N.
    JOURNAL OF WOMENS HEALTH, 2020, 29 (05) : 627 - 635
  • [44] Pregnancy, Fetal, and Infant Outcomes Following Maternal Exposure to Glatiramer Acetate During Pregnancy and Breastfeeding
    Sigal Kaplan
    Mikhail Zeygarnik
    Tal Stern
    Drug Safety, 2022, 45 : 345 - 357
  • [45] THYROID DYSFUNCTION FOLLOWING TREATMENT FOR HODGKIN'S DISEASE
    Tokuc, G.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S312 - S313
  • [46] Thyroid Dysfunction Following Management of Non-thyroid Head and Neck Cancers
    Deepak Rao
    Saumya Shah
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2019, 71 : 447 - 452
  • [47] Thyroid Dysfunction Following Management of Non-thyroid Head and Neck Cancers
    Rao, Deepak
    Shah, Saumya
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2019, 71 (Suppl 1) : 447 - 452
  • [48] Usefulness of thyroid function assessment in infants born to mothers with thyroid dysfunction during pregnancy
    Ben-Zeev, Zohar Steinberg
    Peniakov, Marina
    Felszer, Clari
    Weiner, Scott A.
    Lahad, Avishay
    Almashanu, Shlomo
    Rakover, Yardena Tenenbaum
    EUROPEAN THYROID JOURNAL, 2022, 11 (04)
  • [49] Thyroid Dysfunction and Pregnancy: Where Are We Five Years Later?
    Negro, Roberto
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (08): : 2629 - 2631
  • [50] Thyroid dysfunction in pregnancy - a retrospective observational analysis of a Maltese cohort
    Katia Vella
    Sandro Vella
    C. Savona-Ventura
    J. Vassallo
    BMC Pregnancy and Childbirth, 22